These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9737644)

  • 1. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
    Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
    Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
    Hunninghake DB
    Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety.
    Stein E
    Am J Cardiol; 1998 Aug; 82(4B):40J-46J. PubMed ID: 9737645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
    Saunders E; Ferdinand K; Yellen LG; Tonkon MJ; Krug-Gourley S; Poland M
    J Natl Med Assoc; 2000 Jul; 92(7):319-26. PubMed ID: 10946527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
    Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
    J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerivastatin in primary hyperlipidemia--a multicenter analysis of efficacy and safety.
    Stein E
    Atherosclerosis; 1998 Sep; 139 Suppl 1():S15-22. PubMed ID: 9811154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
    Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
    Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
    Isaacsohn J; Insull W; Stein E; Kwiterovich P; Patrick MA; Brazg R; Dujovne CA; Shan M; Shugrue-Crowley E; Ripa S; Tota R;
    Clin Cardiol; 2001 Sep; 24(9 Suppl):IV1-9. PubMed ID: 11594407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
    Plosker GL; Dunn CI; Figgitt DP
    Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
    Yu WC; Chen CH; Tsao HM; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials.
    Edwards JE; Moore RA
    BMC Fam Pract; 2003 Dec; 4():18. PubMed ID: 14969594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.
    Asztalos BF; Horvath KV; McNamara JR; Roheim PS; Rubinstein JJ; Schaefer EJ
    Atherosclerosis; 2002 Oct; 164(2):361-9. PubMed ID: 12204809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group.
    Betteridge DJ
    Int J Clin Pract; 1999 Jun; 53(4):243-50. PubMed ID: 10563066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
    Farnier M
    Am J Cardiol; 1998 Aug; 82(4B):47J-51J. PubMed ID: 9737646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].
    Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
    Rev Med Interne; 1999 Aug; 20 Suppl 3():393s-398s. PubMed ID: 10480191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
    Stein E; Isaacsohn J; Stoltz R; Mazzu A; Liu MC; Lane C; Heller AH
    Am J Cardiol; 1999 May; 83(10):1433-6. PubMed ID: 10335757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.